Combined Pulsed Dye Laser and Topical Ranibizumab for Treatment of Port Wine Stain Birthmarks

• Status: Withdrawn
• Trial end date: 2013-11-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to improve port wine stain therapeutic outcome in response to laser therapy. The researcher want to determine whether the combined use of pulsed dye laser therapy and topical ranibizumab will improve port wine stain therapeutic outcome.

• Phase: Phase 1
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: University of California, Irvine
• Collaborator: Beckman Laser Institute University of California Irvine
• Treatments: Ranibizumab

Criteria

Inclusion Criteria:

• Port Wine Stain suitable for comparison testing

• Age > 18 years of age

Exclusion Criteria:

• History of photodermatoses or skin cancer

• use of known photosensitizing drugs

• use of immunosuppressive drugs or systemic steroids

• Pregnancy